Public Resistance to Cost-Based Medical Decisions May Raise Premiums to Unaffordable Level, New York Times Op-Ed Says
In Sunday's New York Times "Week in Review" section, Michael Weinstein, a senior fellow at the Council on Foreign Relations and a former Times editorial writer on health care issues, examines how Americans' resistance to allowing to affect medical decisions could increase health insurance premiums to a level that would be unaffordable for many low-income families. The article is avilable online.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
